Clinical Trials Browser

Interventional × Has announcements × dostarlimab × Clear all

NCT02715284 2026-01-13

GARNET

Phase 1 Active not recruiting

730 enrolled 6 FDA

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03981796 2025-09-03

RUBY

Phase 3 Active not recruiting

785 enrolled 4 FDA

Neoplasms, Recurrence